NEW YORK, May 29 – PerkinElmer and MDS Sciex announced an expanded partnership to develop Time-of-Flight-based mass spectrometry systems, the companies announced on Tuesday.
The joint venture will focus on development of proteomics tools and high-throughput protein processing.
“The MS expertise from MDS Sciex adds a critical element to our existing proteomics and biopharmaceutical platforms,” PerkinElmer CEO Gregory Summe said in a statement. “We believe the PerkinElmer Sciex joint venture will enhance our ability to bring new instrumentation and applications to our pharmaceutical customers.”
The new systems are slated for the market in late 2002, according to the companies. Terms of the partnership were not disclosed.
PerkinElmer and MDS Sciex have engaged in joint ventures since 1986. MDS Sciex also has a joint venture with Applied Biosystems for the supply of mass spectrometer-based products for use in drug discovery and development, according to MDS Sciex.